Navigation Links
NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Date:2/1/2008

ANN ARBOR, Mich., Feb. 1 /PRNewswire/ -- NanoBio Corporation is presenting safety and efficacy results on new topical treatments for herpes labialis (cold sores) and onychomycosis (toe nail fungus) at the annual meeting of the American Academy of Dermatology (AAD), being held February 1-5, 2008, in San Antonio.

The data being presented indicate that the company's topical lotions, composed of nanometer-sized droplets, have potent antiviral and antifungal effects without safety concerns or systemic absorption. Interim findings in subjects with cold sores demonstrate faster healing without skin irritation or safety concerns. Initial results in subjects with toe nail fungus indicate an excellent safety profile with no systemic absorption coupled with an ability to kill the fungi that cause onychomycosis, a common condition affecting up to 36 million people.

"We are very encouraged by our preliminary results," said James R. Baker Jr., M.D., founder and chairman of NanoBio Corporation. "Our human and animal studies show that NanoBio's products are well tolerated and without safety issues, adverse events or skin irritation concerns. Pharmacokinetic studies show no systemic absorption, a factor that enhances the safety profile."

Final results from a prior phase 2A study in herpes labialis, as well as interim findings from an ongoing phase 2B study, indicate a significant improvement in time to healing for subjects treated with NanoBio's antiviral product, NB-001.

Results from a phase 1 study in onychomycosis, as well as preclinical data being presented at the meeting, indicate that NanoBio's antifungal product, NB-002, can be safely applied to the skin at doses more than 1,000 times higher than the minimum concentration required to kill fungi.

"NB-002 exerts its effect locally by penetrating the skin and diffusing laterally underneath the nail plate to reach the dermatophytes and kill both active hyphae and spores -- without irritat
'/>"/>

SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... SAN DIEGO, Dec. 1 ADVEN... announced that a new, recently completed preclini...arable toxicity of ANX-514 and Taxotere® (doc...artner for ANX-514 in South Korea, independently c... independent confirmation of the bioequivalence an...
(Date:12/1/2009)..., REDWOOD CITY, Calif., Dec. 1 C...elationship and the signing of its second agreemen...d., the world,s largest generic drug manufacturer....aceutical products. Codexis announced an earlier ...new agreement, Teva will use Codexis biocatalysis ...
(Date:11/30/2009)..., MINNEAPOLIS, Nov. 30 Nonin Medi...nitoring solutions and the inventor of fingertip p...09 North American Product Line Strategy Award in R... secure, accurate remote physiological monitoring,... as a premier provider of telemedicine monitoring ...
Breaking Medicine Technology:ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Codexis Expands Collaboration with Teva 2Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 2Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 3Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital 49893 1Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital 49893 2Stay Upbeat Active to Keep the Mind Young 49889 1Stay Upbeat Active to Keep the Mind Young 49889 2Stay Upbeat Active to Keep the Mind Young 49889 310th CyberKnife System Installed at an HCA Hospital 49885 110th CyberKnife System Installed at an HCA Hospital 49885 210th CyberKnife System Installed at an HCA Hospital 49885 310th CyberKnife System Installed at an HCA Hospital 49885 4
...ug. 4 MonoSol Rx, a specialty,pharmaceutical comp...ology,to develop thin film pharmaceutical products...development for its thin film formulation of,escit...hibitor.,Escitalopram oxalate is indicated for dep...arketed under the brand name Lexapro(R). Lexapro,g...
...III Pivotal Study of Ofatumumab in Refractory CLL ... COPENHAGEN, July 31 Genmab A/S (OMX: GEN) and,G... positive top-line,results from an interim analysi...umab (HuMax-CD20(R)) to treat two groups of chroni...met medical need. At the interim,analysis, the stu...
Other Medicine Technology:MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development 2MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development 3Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 2Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 3Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 4Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 5Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 6
(Date:12/1/2009)..., PHOENIX, Dec. 1 Abrazo Media ...and Scoliosis ( http:// www.pedsorthopaedics.com )...f orthopaedic surgeon Dr. J. Hunt Udall to its pra...ine and orthopaedic surgery after recently complet...in Boston, Massachusetts where he focused on adult...
(Date:12/1/2009)...a, 30 November 2009. Performing surgical operatio...a and has become a reality. This is demonstrated b...atural Orifice Transluminal Endoscopy Surgery), an... access using the body,s natural orifices. The res... scars, shorter hospital stay and faster recovery....
(Date:12/1/2009)...d patients in California are unable to successfull...e at hospitals despite recent state legislation in... a new study. , Posing as low-income uninsured p... less than one-third of the hospitals they approac...her than those allowed under California law, accor...
(Date:12/1/2009)...ardiovascular system tied to academic achievement,...ay News) -- A strong cardiovascular system in youn...r school grades and more overall success later in ...doctors and laypeople know (or should know) the be...s, the authors of a new study, appearing in this w...
(Date:12/1/2009)..., ADDISON, Texas, Dec. 1 For many ...health care is more than just an employee benefit,...mployees. Hobby Lobby Stores, Inc. is leading this...worksite health and wellness center at its corpora... care services directly to employees and their dep...
Breaking Medicine News(10 mins):Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 3Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3
...ss., Aug. 5 Indevus,Pharmaceuticals, Inc. (Nasdaq... of operations for the third quarter ended June 30...d webcast today beginning at 9:00 am,eastern time ...er ended June 30,2008. This compares to revenues o...
... Allsup explains the pros, cons of pu... a long-term disabling event, especially during th...nefits , Belleville, Ill....f a disability, according to http://allsup.com/ ...
... Cenegenics® Medical Institute, t...ced the opening of Cenegenics Indiana. The center...over 2008-2009. The new Cenegenics Indiana will co...d global media attention, such as 60 Minutes, 20/2...
... QHR client hospital Gritman Medical ...ullman Regional Hospital, were recently ranked num...d Medicaid Services (CMS) in "overall patient...sician recruitment and share medical equipment, in...
... The rapid growth in popularity of DN...eptics wrong. A recent poll shows that the benefi..., privacy concerns. From dating, through genealog... Carlsbad, Calif. (PRWEB) August 5, 2008 -...
..., Calif., Aug. 5 Today the United States,Patent &...ntally "Green",low cost process that eliminates th...dants. The patent includes methods for abating pol...esses,there is a significant increase in efficacy ...
Other Medicine News:Health News:Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results 2Health News:Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results 3Health News:Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results 4Health News:Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results 5Health News:Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results 6Health News:Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results 7Health News:Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results 8Health News:Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results 9Health News:Ten Questions to Ask When Considering COBRA Following a Disability 2Health News:Ten Questions to Ask When Considering COBRA Following a Disability 3Health News:Ten Questions to Ask When Considering COBRA Following a Disability 4Health News:Ten Questions to Ask When Considering COBRA Following a Disability 5Health News:Ten Questions to Ask When Considering COBRA Following a Disability 6Health News:Global Leader In Age Management Announces New Indiana Medical Center 2Health News:Global Leader In Age Management Announces New Indiana Medical Center 3Health News:Global Leader In Age Management Announces New Indiana Medical Center 4Health News:Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital 2Health News:Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital 3Health News:DNA Testing and Genetic Profiles Help Avoid Broken Hearts Polls Reveal 2Health News:DNA Testing and Genetic Profiles Help Avoid Broken Hearts Polls Reveal 3Health News:USPTO Issues Patent Embodying Methodologies for Abating a Broad Range of Allergens, Pathogens, Viruses, Bacteria, Odors and Volatile Organic Compounds. 2
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: